Medistim ASA
OSE:MEDI

Watchlist Manager
Medistim ASA Logo
Medistim ASA
OSE:MEDI
Watchlist
Price: 150 NOK -3.85% Market Closed
Market Cap: 2.7B NOK
Have any thoughts about
Medistim ASA?
Write Note
Section:
 
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

MEDI Price Targets Summary
Medistim ASA

Wall Street analysts forecast MEDI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MEDI is 175.44 NOK with a low forecast of 173.72 NOK and a high forecast of 180.6 NOK.

MEDI Lowest Forecast
Wall Street Target
173.72 NOK
16% Upside
MEDI Average Forecast
Wall Street Target
175.44 NOK
17% Upside
MEDI Highest Forecast
Wall Street Target
180.6 NOK
20% Upside
Lowest
Price Target
173.72 NOK
16% Upside
Average
Price Target
175.44 NOK
17% Upside
Highest
Price Target
180.6 NOK
20% Upside
Medistim ASA Competitors:
Price Targets
V
VREX
Varex Imaging Corp
54% Upside
PDEX
Pro-Dex Inc
10% Upside
DXCM
Dexcom Inc
25% Upside
MLAB
Mesa Laboratories Inc
4% Upside
V
VREX
Varex Imaging Corp
54% Upside
PDEX
Pro-Dex Inc
10% Upside
DXCM
Dexcom Inc
25% Upside
MLAB
Mesa Laboratories Inc
4% Upside
DCTH
Delcath Systems Inc
94% Upside
Q
688677
Qingdao NovelBeam Technology Co Ltd
76% Upside
ABT
Abbott Laboratories
16% Upside
V
100120
Vieworks Co Ltd
39% Upside

Revenue
Forecast

Revenue Estimate
Medistim ASA

For the last 8 years the compound annual growth rate for Medistim ASA's revenue is 10%. The projected CAGR for the next 3 years is 4%.

10%
Past Growth
4%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Medistim ASA

For the last 8 years the compound annual growth rate for Medistim ASA's operating income is 12%. The projected CAGR for the next 3 years is 5%.

12%
Past Growth
5%
Estimated Growth
Estimates Accuracy
-8%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Medistim ASA

For the last 8 years the compound annual growth rate for Medistim ASA's net income is 13%. The projected CAGR for the next 3 years is 4%.

13%
Past Growth
4%
Estimated Growth
Estimates Accuracy
-7%
Average Miss
What are analyst estimates?

See Also

Summary
MEDI intrinsic value, competitors valuation, and company profile.
DCF Valuation
MEDI stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MEDI stock valuation using valuation multiples.
Wall Street Estimates
MEDI price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MEDI stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MEDI's stock price target?
Price Target
175.44 NOK

According to Wall Street analysts, the average 1-year price target for MEDI is 175.44 NOK with a low forecast of 173.72 NOK and a high forecast of 180.6 NOK.

What is Medistim ASA's Revenue forecast?
Projected CAGR
4%

For the last 8 years the compound annual growth rate for Medistim ASA's revenue is 10%. The projected CAGR for the next 3 years is 4%.

What is Medistim ASA's Operating Income forecast?
Projected CAGR
5%

For the last 8 years the compound annual growth rate for Medistim ASA's operating income is 12%. The projected CAGR for the next 3 years is 5%.

What is Medistim ASA's Net Income forecast?
Projected CAGR
4%

For the last 8 years the compound annual growth rate for Medistim ASA's net income is 13%. The projected CAGR for the next 3 years is 4%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 210,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.